Skip to main content

Jemperli Prices, Coupons and Patient Assistance Programs

Jemperli (dostarlimab) is a member of the anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) drug class and is commonly used for Endometrial Cancer, and Solid Tumors.

The cost for Jemperli intravenous solution (gxly 500 mg/10 mL) is around $11,947 for a supply of 10 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Jemperli prices

Intravenous Solution

Quantity Per unit Price
10 milliliters $1,194.67 $11,946.72

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Jemperli Coupons, Copay Cards and Rebates

Jemperli offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Jemperli Together with GSK Oncology Co-pay Program

Eligible commercially insured patients may pay $0 per treatment with a maximum annual savings of $26,000; patients who receive treatment from their healthcare provider may receive assistance for up to $100 for each in-office administration; for more information contact the program at 844-447-5662.

Applies to:
Number of uses:
per prescription per year

Form more information phone: 844-447-5662 or Visit website

Patient Assistance & Copay Programs for Jemperli

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Jemperli (dostarlimab-gxly) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: Together with GSK Oncology

Eligibility requirements:
  1. Determined case by case
  2. At or below 500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must reside in the US, DC, Puerto Rico or the USVI
  5. This program provides copay assistance. Contact the program for more detail. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
Applicable drugs:
  • Jemperli (dostarlimab-gxly) Injection; IV

More information please phone: 844-447-5662 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.